Skip to main content
. 2022 May 10;12:880636. doi: 10.3389/fcimb.2022.880636

Figure 8.

Figure 8

Investigation of the prognostic potential of the risk signature. (A–D) Survival analyses conducted on patients with distinct biological background, including age and gender. (E) Univariate COX regression analysis in the merged cohort. (F) Multivariate COX regression analysis in the merged cohort. (G) Evaluation of the risk score of samples with different future status. (H) Percentage of the alive and dead samples in low- and high-risk score groups, respectively.